Related Experiment Video
Updated: Aug 11, 2025

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection
Published on: May 24, 2020
Mpox-A Rapidly Evolving Disease.
Edward W Cowen1, Eric R Tkaczyk2,3, Scott A Norton4
1Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
The 2022 mpox outbreak presents with distinct skin lesions that can mimic other infections. Understanding the evolution of mpox symptoms is crucial for accurate diagnosis and management.
Area of Science:
- Dermatology
- Infectious Diseases
- Public Health
Background:
- The 2022 mpox outbreak emerged globally during the ongoing COVID-19 pandemic.
- Mpox clinical presentation often includes skin findings, potentially misdiagnosed as sexually transmitted infections.
- Accurate identification of mpox dermatological manifestations is critical for patient care.
Purpose of the Study:
- To provide an overview of the evolution of mpox skin findings.
- To trace the historical changes in mpox presentation since its initial human description.
- To aid clinicians in differentiating mpox from other skin conditions.
Main Methods:
- Review of historical and contemporary clinical descriptions of mpox.
- Analysis of dermatological manifestations reported in the 1970s and the 2022 outbreak.
- Synthesis of information on the changing clinical presentation of mpox.
Main Results:
- Mpox skin findings have evolved since its initial recognition in humans in 1970.
- The current outbreak's presentation may differ from historical cases, posing diagnostic challenges.
- Dermatological manifestations are a key feature distinguishing mpox from COVID-19.
Conclusions:
- Understanding the evolution of mpox skin lesions is essential for timely diagnosis.
- Clinical vigilance is required to differentiate mpox from other dermatological conditions.
- This overview aids in recognizing the diverse presentations of mpox.
More Related Videos
11:44Generation and Multi-phenotypic High-content Screening of Coxiella burnetii Transposon Mutants
Published on: May 13, 2015
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Methods of Documentation II: POMR
Pneumonia III: Complications and Assessment